Get the Stockscreener App
114.66
1.05%
1.19
Veradermics Inc stock is traded at $114.66, with a volume of 368.27K.
It is up +1.05% in the last 24 hours and up +10.37% over the past month.
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
See More
Previous Close:
$113.47
Open:
$112.74
24h Volume:
368.27K
Relative Volume:
0.36
Market Cap:
$4.79B
Revenue:
Net Income/Loss:
P/E Ratio:
-121.98
EPS:
-0.94
Net Cash Flow:
1W Performance:
-9.45%
1M Performance:
+10.37%
6M Performance:
+42.43%
1Y Performance:
+0.00%
1-Day Range:
$111.05
$115.99
1-Week Range:
$112.61
$135.12
52-Week Range:
$32.00
$136.72
Veradermics Inc Stock (MANE) Company Profile
Name
Veradermics Inc
Sector
Industry
Phone
228.372.3376
Address
470 JAMES STREET, NEW HAVEN
Compare MANE vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MANE
Veradermics Inc
|
114.66 | 4.79B | 0 | 0 | 0 | -0.94 |
VRTX
Vertex Pharmaceuticals Inc
|
509.74 | 129.20B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
238.40 | 95.18B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
801.26 | 82.49B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
849.01 | 53.39B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
371.37 | 42.01B | 5.76B | 514.49M | 1.10B | 4.4813 |
Veradermics Inc Stock (MANE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-26 | Initiated | B. Riley Securities | Buy |
| Jun-02-26 | Initiated | Needham | Buy |
| Mar-02-26 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-26 | Initiated | Citigroup | Buy |
| Mar-02-26 | Initiated | Jefferies | Buy |
| Mar-02-26 | Initiated | Leerink Partners | Outperform |
View All
Veradermics Inc Stock (MANE) Latest News
JPMorgan Chase reports a passive stake above 5% in Veradermics (MANE). - Stock Titan
Veradermics: The Momentum Is Building, But Know This Before The H2 2026 Readouts (MANE) - Seeking Alpha
Veradermics (NYSE:MANE) Hits New 12-Month HighHere's What Happened - MarketBeat
MANE Stock Jumps As Traders Zero In On Momentum - StocksToTrade
MANE Stock Surges As Traders Target Volatile Breakout - Timothy Sykes
MANE Stock Surges As Traders Target Volatile Breakout - Timothy Sykes
MANE Stock Jumps On High Volume As Bulls Test Breakout - StocksToTrade
MANE Stock Jumps As Traders Pile Into Volatile Breakout - Timothy Sykes
MANE Stock Jumps As Traders Pile Into Volatile Breakout - Timothy Sykes
MANE Stock Pops On Volatile Rally As Traders Pile In - StocksToTrade
Veradermics (NYSE:MANE) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Veradermics (NYSE:MANE) Aktienprognose & Analystenprognosen - Simply Wall Street
Veradermics (NYSE:MANE) Stock Forecast & Analyst Predictions - Simply Wall Street
Veradermics (NYSE:MANE) Stock Jumps 3.4%Time to Buy? - MarketBeat
Veradermics (NYSE:MANE) Stock Falls 8.1%Here's What Happened - MarketBeat
Top Veradermics (MANE) Competitors 2026 - MarketBeat
Veradermics (NYSE:MANE) Trading 6.1% HigherWhat's Next? - MarketBeat
Veradermics, Incorporated (NYSE:MANE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Veradermics: Buy Before The Catalysts (NYSE:MANE) - Seeking Alpha
Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic - Yahoo Finance
Citi Keeps Their Buy Rating on Veradermics, Incorporated (MANE) - theglobeandmail.com
Veradermics at Cantor healthcare conference: hair-loss market in focus By Investing.com - Investing.com Canada
Veradermics at Cantor healthcare conference: hair-loss market in focus - Investing.com
Veradermics at citigroup summit: oral hair-loss drug nears key data - Investing.com Nigeria
Veradermics at citigroup summit: oral hair-loss drug nears key data - investing.com
Wellington Management Group LLP Buys Shares of 68,531 Veradermics, Incorporated $MANE - MarketBeat
Veradermics (MANE) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
Seven Fleet Capital Management LP Purchases Shares of 80,000 Veradermics, Incorporated $MANE - MarketBeat
Hollander David Receives 9,650 Shares and 19,300 Derivative Securities from Veradermics on September 1, 2026 - Kalkine Media
Veradermics (MANE) R&D chief receives new stock and option awards - Stock Titan
Veradermics to Present at Upcoming September Investor Conferences - Yahoo Finance
Veradermics (MANE) Stock Looks Overvalued After Its 161% Rally - Yahoo Finance
Is Veradermics (MANE) Still Undervalued After Its 161% Year To Date Run? - Yahoo Finance
Hair Loss Biotechs Emerge As Wall Street's Newest Growth Trade - Yahoo Finance
Forget GLP-1 Stocks, Baldness Drugs Are Wall Street’s Next Goldmine - Bloomberg.com
Veradermics, Incorporated (NYSE:MANE) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Bamco Inc. NY Purchases 169,913 Shares of Veradermics, Incorporated $MANE - MarketBeat
Why is Veradermics stock sliding today? By Investing.com - Investing.com Canada
Why is Veradermics stock sliding today? By Investing.com - Investing.com Nigeria
Veradermics stock falls following insider share sale By Investing.com - Investing.com Nigeria
Veradermics (NYSE:MANE) Director Sells 750,000 Shares - MarketBeat
Veradermics (MANE) backer exercises $0.00001 per share warrants - Stock Titan
Veradermics (NASDAQ: MANE) insider sells stock in two August trades - Stock Titan
Veradermics (MANE) R&D chief enters insider ranks with no stake - Stock Titan
Veradermics (NYSE:MANE) Stock Price Down 7.9%Here's Why - MarketBeat
Veradermics (MANE) affiliate plans NYSE sale via BofA Securities - Stock Titan
Form 144 | Veradermics(MANE.US) Insider Proposes to Sell 6.37 Million in Common Stocks - Moomoo
Veradermics Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
Veradermics CEO Reid Alexander Waldman disposes of common shares worth $7.24 million - Bitget
Veradermics (NYSE:MANE) Insider Timothy August Durso Sells 43,500 Shares - MarketBeat
Veradermics Inc Stock (MANE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Veradermics Inc Stock (MANE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Averill Madison Master Fund, L | Affiliate |
Aug 19 '26 |
Proposed Sale |
107.25 |
59,399 |
6,370,543 |
0 |
| Averill Master Fund, Ltd. | Affiliate |
Aug 19 '26 |
Proposed Sale |
107.25 |
690,601 |
74,066,957 |
0 |
| Timothy Durso | Officer |
Aug 17 '26 |
Proposed Sale |
111.28 |
87,000 |
9,681,360 |
0 |
| Waldman Reid Alexander | Chief Executive Officer |
Aug 17 '26 |
Sale |
107.86 |
67,500 |
7,280,713 |
170,824 |
| Waldman Reid Alexander | Chief Executive Officer |
Aug 17 '26 |
Option Exercise |
12.19 |
3,452 |
42,080 |
238,324 |
| Durso Timothy August | Chief Technical Officer |
Aug 17 '26 |
Option Exercise |
12.19 |
3,452 |
42,080 |
121,642 |
| Durso Timothy August | Chief Technical Officer |
Aug 17 '26 |
Sale |
107.82 |
43,500 |
4,690,005 |
78,142 |
| Reid Alexander Waldman | CEO |
Aug 17 '26 |
Proposed Sale |
111.28 |
135,000 |
15,022,800 |
0 |
| CHILDS JOHN W | Director |
Aug 12 '26 |
Sale |
107.12 |
100,000 |
10,711,700 |
194,117 |
| AMZL, LP | Shareholder |
Aug 12 '26 |
Proposed Sale |
108.95 |
104,587 |
11,394,754 |
0 |
3.72%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):